Floatz logo

VINCRISTINE SULFATE

Ph-Like Acute Lymphoblastic Leukemia

City of Hope Medical CenterSmall moleculePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Ph-Like Acute Lymphoblastic Leukemia cohort.

Asset / SponsorPhaseRating
PREDNISONE TABLETS
City of Hope Medical Center
Phase 2B
Cytosin-Arabinosid
City of Hope Medical Center
Phase 2B
METHOTREXATE
City of Hope Medical Center
Phase 2B
MERCAPTOPURINE ANHYDROUS
City of Hope Medical Center
Phase 2B
Cyclophosphamide
City of Hope Medical Center
Phase 2B

View all 16 →

Same molecule, other indications

VINCRISTINE SULFATE is also rated in:

B-cell childhood acute lymphoblastic leukemiaDormant
A
Indicative ·
81 / 100
View asset →
diffuse large B-cell lymphomaDormant
A
Indicative ·
80 / 100
View asset →
Burkitt lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →